Latest

latest

Bernstein said covid19 vaccine may be available in india by early 2021

Bernstein said covid19 vaccine may be available in india by early 2021. As the trial of the coronavirus vaccine is progressing at a rapid pace, the expectation of an approved vaccine becoming available in the Indian market by early 2021 is increasing. Bernstein said this in a report.

Saturday, August 29, 2020

/ by Avishek Bera
corona virus, Coronavirus, covid-19, News cover, the news cover, vaccine, corona virus vaccine

News Cover: As the trial of the coronavirus vaccine is progressing at a rapid pace, the expectation of an approved vaccine becoming available in the Indian market by early 2021 is increasing. Bernstein said this in a report.

Currently, there are four potential vaccines globally, which are expected to be approved by the end of 2020 or early 2021. Two of these vaccines have been partnered by 'AstraZeneca and Oxford's viral vector vaccine' and 'Novavax's protein subunit vaccine'.

According to the report, 'First and second stage tests seem to be reliable in increasing the safety and immune response potential for these two vaccines. We are optimistic that an approved vaccine will be available in the market in the first quarter of 2021 in India.

Vaccine price

Bernstein said that the cost of the vaccine can be three to six dollars (225 to 550 rupees) per dose, and collective immunity can take up to two years to develop due to implementation difficulties. The reason for this is the lack of experience in terms of mass vaccination.

Challenges to be faced by India

Bernstein said that the number of cold stores and shortage of skilled labor are two major challenges. Even assuming that the pace of implementation will be two times than before, it will still take 18 to 20 months for the government program to be implemented.

He said, 'We believe that initially vaccines will be made available to sensitive sections like health workers and people above 65 years of age etc. After this, the vaccine can be given to people engaged in essential services and to the economically poor.

According to the report, Novavax vaccine is giving better results than AstraZeneca and Oxford. Both have given good results in the first two phases and are now in the third phase. For this, a person will need to give two doses in an interval of 21 to 28 days.

Bernstein said that the Serum Institute of India is fully ready to introduce the vaccine first. The Serum Institute has tied up with AstraZeneca and both Oxford and Novavax to produce their potential vaccines. It has the ability to produce both a protein sub unit and a viral vector vaccine. If required, the ability of both types can be increased by changing one. We do not see any hindrance on the manufacturing front.

He said, 'Serum Institute is also working on additional capacity of one billion doses. We estimate that they will be able to produce 60 crore doses in 2021 and one billion doses in 2022. Of these, 40 to 50 crore doses will be available for India in 2021.

Apart from this, three companies of India, Zydus, Bharat Biotech and Biological are also working on their own vaccines. These vaccines are in Phase I and Phase II trials.

No comments

Post a Comment

WE WISH FOR A POLLUTION FREE INDIA
News Cover © all rights reserved
made with by templateszoo